Myositis is a disorder in which the immune system attacks the muscles. It is hoped that this new treatment may help improve the symptoms of this disease.

Research Objectives

Status

Current

Recruitment

Open

Patient Group

Idiopathic Inflammatory Myopathy/Myositis Status: Current

Study location

Wesley Research Institute

Phase

3

Study type

Industry Sponsored

Sponsors: Argenx BV (global) and ICON Clinical Research Pty Ltd (Local)

    Lead investigator    
            Dr Daman Langguth        

        Clinical trial coordinator		
				Venita Bali			

Technical title

A Phase 2/3, Randomized, Double-Blinded, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy, Safety, Tolerability, Pharmacodynamics, Pharmacokinetics, and Immunogenicity of Efgartigimod PH20 SC in Adult Participants With Active Idiopathic Inflammatory Myopathies

About this research project

The research project is testing a new treatment for Active Idiopathic Inflammatory Myopathy. This is a disorder in which the immune system attacks the muscles. This leads to muscle weakness and may affect other organs of the body.

The potential new treatment being tested is called efgartigimod (also called ARGX113). It is hoped that efgartigimod may help improve the symptoms of myositis.

Latest News

Breath of fresh air for Clinical Trial participant, Tim

Husband and father of three Tim, was diagnosed with Chronic Obstructive Pulmonary Disease, sometimes known as emphysema, in 2019, when he was 56 years old. Tim participated in a trial for patients with severe emphysema, undergoing two minimally invasive procedures, aimed at improving his lung function.

Coeliac Disease Webinar Series

Are you or a loved one living with coeliac disease? Join us for an engaging and informative webinar designed to explore the challenges, breakthroughs and future pathways in managing this complex disease. Kicking off on Tuesday, 28 January 2025, the first webinar, Living with Coeliac Disease – Pathways to Treatment.

QSBC researchers shine at Multi-Omics 2024!

Queensland Spatial Biology Centre researchers had an action-packed few days at the Multi-Omics 2024 conference held in Brisbane last week.

1 2 3 … 17 Next »

Rare Diseases

Testing treatments to improve symptoms of Myositis